The Oncosearch | Oncotarget

Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67: First steps of precision medicine at SCLC Research Paper

Samuel Silva, Juliana C. Sousa, Cleto Nogueira, Raquel Feijo, Francisco Martins Neto, Laura Cardoso Marinho, Guilherme Sousa, Valeria Denninghoff, Fabio Tavora

Published Oct 4, 2024 · Vol. 15, No. 1 · pp. 750-763

Keywords: DLL3, pathology, biomarkers, qupath, small cell carcinoma

Addendum: Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Addendum

Birgitta Hiddinga, Karen Zwaenepoel, Annelies Janssens, Jan Van Meerbeeck, Patrick Pauwels

Published Sep 7, 2023

Addendum: Analysis of pituitary adenoma expression patterns suggests a potential role for the NeuroD1 transcription factor in neuroendocrine tumor-targeting therapies Addendum

Lubov Borisovna Mitrofanova, Olga Mikhailovna Vorobeva, Andrey Nikolaevich Gorshkov

Published Feb 7, 2023

Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors Addendum

Venkata S.K. Manem, Olga Sazonova, Andréanne Gagné, Michèle Orain, Babak Khoshkrood-Mansoori, Nathalie Gaudreault, Yohan Bossé, Philippe Joubert

Published Nov 23, 2022 · Vol. 13, No. 1 · pp. 1302-1302

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Jun Gong, Michelle Guan, Haesoo Kim, Natalie Moshayedi, Sejal Mehta, Galen Cook-Wiens, Brent K. Larson, Jenny Zhou, Rishi Patel, Isaac Lapite, Veronica R. Placencio-Hickok, Richard Tuli, Ronald B. Natale, Andrew E. Hendifar

Published Oct 25, 2022 · Vol. 13, No. 1 · pp. 1202-1214

Keywords: hyaluronan, hyaluronic acid, biomarker, prognostic, predictive

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Research Paper

Birgitta Hiddinga, Karen Zwaenepoel, Annelies Janssens, Jan Van Meerbeeck, Patrick Pauwels

Published May 13, 2022 · Vol. 13, No. 1 · pp. 800-809

Keywords: MGMT promoter methylation, anaplastic lymphoma kinase, neuroendocrine tumor, neuroendocrine carcinoma, small cell lung cancer

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Ami N. Shah, Ashwin Sunderraj, Brian Finkelman, Sharlene H. See, Andrew A. Davis, Lorenzo Gerratana, Firas Wehbe, Neelima Katam, Deva Mahalingam, William J. Gradishar, Amir Behdad, Luis Blanco, Massimo Cristofanilli

Published Jan 26, 2022 · Vol. 13, No. 1 · pp. 273-280

Keywords: ERBB2, HER2, next-generation sequencing, copy number gain, circulating tumor DNA

Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors Research Paper

Venkata S.K. Manem, Olga Sazonova, Andréanne Gagné, Michèle Orain, Babak Khoshkrood-Mansoori, Nathalie Gaudreault, Yohan Bossé, Philippe Joubert

Published Jan 22, 2021 · Vol. 12, No. 3 · pp. 209-220

Keywords: mitotic index, Ki-67, transcriptomics, lung neuroendocrine tumors, pathway analysis

MicroRNA-based regulation of Aurora A kinase in breast cancer Research Paper

Adewale Oluwaseun Fadaka, Nicole Remaliah Samantha Sibuyi, Abram Madimabe Madiehe, Mervin Meyer

Published Nov 6, 2020 · Vol. 11, No. 46 · pp. 4306-4324

Keywords: AURKA, breast cancer therapy, regulatory microRNA, human argonaute, gene expression

What is the role of checkpoint inhibitors in neuroendocrine neoplasms? Editorial

Taymeyah Al-Toubah, Eleonora Pelle, Jonathan Strosberg

Published Oct 4, 2020 · Vol. 11, No. 42 · pp. 3751-3752

Keywords: neuroendocrine neoplasm, neuroendocrine tumor, neuroendocrine carcinoma, immunotherapy, PD-1 inhibitor

Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin’s lymphoma to many other types of solid cancers Research Paper

Rod Balhorn, Monique Cosman Balhorn

Published Aug 5, 2020 · Vol. 11, No. 35 · pp. 3315-3349

Keywords: HLA-DR, selective high affinity ligand, SH7139, SH7129, solid cancers

Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients Research Paper

Aman Chauhan, Riham El-Khouli, Timothy Waits, Rohitashva Agrawal, Fariha Siddiqui, Zachary Tarter, Millicent Horn, Heidi Weiss, Elizabeth Oates, B. Mark Evers, Lowell Anthony

Published Jul 22, 2020 · Vol. 11, No. 32 · pp. 3061-3068

Keywords: gallium-68 DOTATATE, neuroendocrine diagnosis, NET

Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice Research Paper

Eugenia Y. Xu, Evan Vosburgh, Chung Wong, Laura H. Tang, Daniel A. Notterman

Published Jun 20, 2020 · Vol. 11, No. 28 · pp. 2718-2739

Keywords: neuroendocrine tumors, RB1, Trp53, PTEN, Men1

Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours Research Paper

Lisi Elizabeth Lim, David L. Chan, David Thomas, Yang Du, Gary Tincknell, Anna Kuchel, Alexander Davis, Dale L. Bailey, Nick Pavlakis, Gabrielle Cehic, William Macdonald, David Wyld, Eva Segelov

Published Jun 20, 2020 · Vol. 11, No. 27 · pp. 2636-2646

Keywords: lung, carcinoid, atypical, neuroendocrine, peptide receptor radionuclide therapy

Exploring the role of survivin in neuroendocrine neoplasms Research Paper

Ahmad Hanif, Sunyoung Lee, Medhavi Gupta, Ankush Chander, Eric D. Kannisto, Achamaporn Punnanitinont, Robert Fenstermaker, Michael Ciesielski, Kristopher Attwood, Jingxin Qiu, Sai Yendamuri, Renuka Iyer

Published May 26, 2020 · Vol. 11, No. 23 · pp. 2246-2258

Keywords: neuroendocrine tumors, survivin, immunohistochemistry, biomarkers, radiosensitivity

Neuroendocrine carcinoma of uterine cervix findings shown by MRI for staging and survival analysis – Japan multicenter study Research Paper

Kazuhiro Kitajima, Takako Kihara, Yusuke Kawanaka, Aki Kido, Kotaro Yoshida, Yasunari Mizumoto, Akiko Tomiyama, Shigeo Okuda, Masahiro Jinzaki, Fumi Kato, Junko Takahama, Akiko Takahata, Yoshihiko Fukukura, Atsushi Nakamoto, Tetsuya Tsujikawa, Jiro Munechika, Yoshimitstu Ohgiya, Nobuyuki Kawai, Satoshi Goshima, Ayumi Ohya, Yasunari Fujinaga, Takeru Fukunaga, Shinya Fujii, Masahiro Tanabe, Katsuyoshi Ito, Takahiro Tsuboyama, Yuichiro Kanie, Shigeaki Umeoka, Shintaro Ichikawa, Utaroh Motosugi, Sayaka Daido, Ayumu Kido, Tsutomu Tamada, Mitsuru Matsuki, Tsuneo Yamashiro, Koichiro Yamakado

Published May 21, 2020 · Vol. 11, No. 40 · pp. 3675-3686

Keywords: cervical cancer, neuroendocrine carcinoma, small cell carcinoma, large cell carcinoma, MRI

Blood-based next-generation sequencing analysis of neuroendocrine neoplasms Research Paper

Katerina Zakka, Rebecca Nagy, Leylah Drusbosky, Mehmet Akce, Christina Wu, Olatunji B. Alese, Bassel F. El-Rayes, Pashtoon Murtaza Kasi, Kabir Mody, Jason Starr, Walid L. Shaib

Published Apr 26, 2020 · Vol. 11, No. 19 · pp. 1749-1757

Keywords: neuroendocrine neoplasm, neuroendocrine tumor, neuroendocrine carcinoma, next-generation sequencing, circulating tumor DNA

Prognostic value of a three-scale grading system based on combining molecular imaging with ⁶⁸Ga-DOTATATE and ¹⁸F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias Research Paper

Ioannis Karfis, Gwennaëlle Marin, Hugo Levillain, Stylianos Drisis, Raoul Muteganya, Gabriela Critchi, Loubna Taraji-Schiltz, Carlos Artigas Guix, Leila Shaza, Meriem Elbachiri, Laura Mans, Godelieve Machiels, Alain Hendlisz, Patrick Flamen

Published Feb 11, 2020 · Vol. 11, No. 6 · pp. 589-599

Keywords: gastroenteropancreatic neuroendocrine neoplasias, molecular imaging, prognostic biomarkers, ⁶⁸Ga-DOTATATE PET/CT, ¹⁸F-FDG PET/CT

Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignancies Research Paper

Richard K. Yang, Yun Qing, Fatima Zahra Jelloul, Mark J. Routbort, Peng Wang, Kenna Shaw, Jiexin Zhang, Jack Lee, L. Jeffrey Medeiros, Scott Kopetz, Michael T. Tetzlaff, Russell R. Broaddus

Published Feb 11, 2020 · Vol. 11, No. 6 · pp. 600-618

Keywords: biomarkers, immunotherapy, mutations, TMB, histology

Efficacy of a third-generation oncolytic herpes simplex virus in neuroendocrine tumor xenograft models Research Paper

Hideyuki Matsushima, Masaki Kaibori, Masahiko Hatta, Morihiko Ishizaki, Richi Nakatake, Tadayoshi Okumura, Kengo Yoshii, Tomoki Todo

Published Dec 24, 2019 · Vol. 10, No. 67 · pp. 7132-7141

Keywords: oncolytic virus, herpes simplex virus, neuroendocrine tumor, mouse xenograft model

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67: First steps of precision medicine at SCLC Research Paper

Addendum: Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Addendum

Addendum: Analysis of pituitary adenoma expression patterns suggests a potential role for the NeuroD1 transcription factor in neuroendocrine tumor-targeting therapies Addendum

Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors Addendum

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Research Paper

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors Research Paper

MicroRNA-based regulation of Aurora A kinase in breast cancer Research Paper

What is the role of checkpoint inhibitors in neuroendocrine neoplasms? Editorial

Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin’s lymphoma to many other types of solid cancers Research Paper

Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients Research Paper

Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice Research Paper

Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours Research Paper

Exploring the role of survivin in neuroendocrine neoplasms Research Paper

Neuroendocrine carcinoma of uterine cervix findings shown by MRI for staging and survival analysis – Japan multicenter study Research Paper

Blood-based next-generation sequencing analysis of neuroendocrine neoplasms Research Paper

Prognostic value of a three-scale grading system based on combining molecular imaging with ⁶⁸Ga-DOTATATE and ¹⁸F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias Research Paper

Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignancies Research Paper

Efficacy of a third-generation oncolytic herpes simplex virus in neuroendocrine tumor xenograft models Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67: First steps of precision medicine at SCLC Research Paper

Addendum: Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Addendum

Addendum: Analysis of pituitary adenoma expression patterns suggests a potential role for the NeuroD1 transcription factor in neuroendocrine tumor-targeting therapies Addendum

Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors Addendum

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Research Paper

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors Research Paper

MicroRNA-based regulation of Aurora A kinase in breast cancer Research Paper

What is the role of checkpoint inhibitors in neuroendocrine neoplasms? Editorial

Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin’s lymphoma to many other types of solid cancers Research Paper

Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients Research Paper

Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice Research Paper

Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours Research Paper

Exploring the role of survivin in neuroendocrine neoplasms Research Paper

Neuroendocrine carcinoma of uterine cervix findings shown by MRI for staging and survival analysis – Japan multicenter study Research Paper

Blood-based next-generation sequencing analysis of neuroendocrine neoplasms Research Paper

Prognostic value of a three-scale grading system based on combining molecular imaging with 68Ga-DOTATATE and 18F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias Research Paper

Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignancies Research Paper

Efficacy of a third-generation oncolytic herpes simplex virus in neuroendocrine tumor xenograft models Research Paper

Prognostic value of a three-scale grading system based on combining molecular imaging with ⁶⁸Ga-DOTATATE and ¹⁸F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias Research Paper